CompletedNot Applicable

Efficacy of Winterized Pistacia Lentiscus Oil in Reducing Purulent Bacterial Overinfection of Pediatric Rhinitis

Italy105 participantsStarted 2025-01-02

Plain-language summary

This study aims to evaluate the efficacy and safety of a medical device containing winterized Pistacia lentiscus oil in reducing symptoms of purulent bacterial overinfection in pediatric rhinitis and the need for antibiotic therapy. The randomized controlled trial will compare the treatment group receiving nasal drops with a control group using saline solution.

Who can participate

Age range2 Years – 10 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children aged 2 to 10 years. * Clinical symptoms of dense mucosal rhinitis/purulent mucus. * Onset of symptoms ≤ 5 days before enrollment. Exclusion Criteria: * Onset of symptoms \> 5 days before enrollment. * Presence of neurological, malformative, or immunological pathology. * Suspected or confirmed allergy to the active substance. * Use of antibiotics within 48 hours prior to enrollment.

What they're measuring

Change in Purulent Rhinitis Symptoms

Timeframe: 6 days

Trial details

NCT IDNCT06758804

SponsorLiaquat University of Medical & Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-03

View on ClinicalTrials.gov More Rhinitis Acute trials